Literature DB >> 27214074

IV pentamidine for Pneumocystis jiroveci pneumonia prophylaxis in pediatric allogeneic stem cell transplant patients.

D A Curi1, R E Duerst1, C Badke2, J Bell3, S Chaudhury1, M Kletzel1, J Schneiderman1, W T Tse1, W J Muller4, N Hijiya1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27214074     DOI： 10.1038/bmt.2016.133

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

1.  Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.

Authors:  M J Vasconcelles; M V Bernardo; C King; E A Weller; J H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2000       Impact factor: 5.742

2.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

Review 3.  Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.

Authors:  Anat Stern; Hefziba Green; Mical Paul; Liat Vidal; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2014-10-01

4.  IV pentamidine for primary PJP prophylaxis in adults undergoing allogeneic hematopoietic progenitor cell transplant.

Authors:  M J Lim; A Stebbings; S J Lim; K Foor; J-Z Hou; R Farah; A Raptis; S Marks; D Weber; A Im; K Dorritie; A Sehgal; M Agha; S H Lim
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

5.  Intravenous pentamidine for Pneumocystis carinii/jiroveci pneumonia prophylaxis in pediatric transplant patients.

Authors:  Abigail Clark; Trina Hemmelgarn; Lara Danziger-Isakov; Ashley Teusink
Journal:  Pediatr Transplant       Date:  2015-02-25

6.  No occurrence of Pneumocystis jiroveci (carinii) pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation.

Authors:  A Tomonari; S Takahashi; J Ooi; N Tsukada; T Konuma; S Kato; S Kasahara; T Iseki; A Tojo; S Asano
Journal:  Transpl Infect Dis       Date:  2008-06-28       Impact factor: 2.228

7.  Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia.

Authors:  J Ena; C Amador; F Pasquau; C Carbonell; C Benito; F Gutiérrez; A Vilar
Journal:  Clin Infect Dis       Date:  1994-06       Impact factor: 9.079

8.  A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.

Authors:  S A Bozzette; D M Finkelstein; S A Spector; P Frame; W G Powderly; W He; L Phillips; D Craven; C van der Horst; J Feinberg
Journal:  N Engl J Med       Date:  1995-03-16       Impact factor: 91.245

9.  Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; S Kuhn; S Chaudhary; S Feldman; M Verzosa; R J Aur; C Pratt; S L George
Journal:  N Engl J Med       Date:  1977-12-29       Impact factor: 91.245

10.  Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.

Authors:  Su Young Kim; Alix A Dabb; Donald J Glenn; Kristen M Snyder; Meredith K Chuk; David M Loeb
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167
View more
  3 in total

1.  Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.

Authors:  Melissa Quinn; J T Fannin; Joseph Sciasci; Allison Bragg; Patrick K Campbell; Delia Carias; Kristine R Crews; David Gregornik; Sima Jeha; Gabriela Maron; Jennifer L Pauley; Hope D Swanson; Joshua Wolf; William Greene
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

2.  Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.

Authors:  Wedad B Awad; Alaa Asaad; Nardin Al-Yasein; Rula Najjar
Journal:  BMC Infect Dis       Date:  2020-06-05       Impact factor: 3.090

3.  Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO).

Authors:  Annika Y Classen; Larissa Henze; Marie von Lilienfeld-Toal; Georg Maschmeyer; Michael Sandherr; Luisa Durán Graeff; Nael Alakel; Maximilian Christopeit; Stefan W Krause; Karin Mayer; Silke Neumann; Oliver A Cornely; Olaf Penack; Florian Weißinger; Hans-Heinrich Wolf; Jörg Janne Vehreschild
Journal:  Ann Hematol       Date:  2021-04-13       Impact factor: 3.673
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.